In the pathological context, astrocytes isolated from MS lesions expressed greater mRNA levels of the enzyme responsible for the ceramides production (ceramide-producing enzyme acid sphingomyelinase (ASM)) compared to astrocytes from control white matter. The gene discussed is SMPD1; the disease is myeloid sarcoma.